Related Experiment Video
Updated: Mar 29, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Indole Alkaloids as Biased Opioid Receptor Modulators
Oliver Grundmann1, Allison Henderson1
1Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA.
Abstract:
Background: Opioid receptors are a commonly used target for treatment of pain conditions. Most opioids used in therapy are linked to adverse effects such as tolerance, dependence, and respiratory depression. Indole alkaloids acting on opioid receptors may provide a novel molecular mechanism to confer analgesic effects. Results: Indole alkaloids such as ibogaine and mitragynine act on μ-opioid receptors as biased full or partial agonists that do not, or much less strongly, recruit β-arrestin compared to non-biased agonists. The recruitment of β-arrestin has been linked to adverse effects, most notably substantial respiratory depression. The molecular mechanism of biased activation has been proposed to be associated with accommodation of the indole structure that leads to a different spatial orientation of amino acid residues in transmembrane regions 2 and 3 of the μ-opioid receptor as well as extracellular helix 8. Conclusions: Naturally occurring indole alkaloids show biased G-protein coupled activation of opioid receptors with limited recruitment of β-arrestin, thus limiting commonly observed adverse effects. Indole alkaloids may present a feasible structure to develop new biased opioid modulators with an improved risk-to-benefit ratio.
Insights
Indole alkaloids, like ibogaine and mitragynine, act as biased agonists on opioid receptors. This biased activation limits adverse effects such as respiratory depression, offering a promising avenue for safer pain management.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Opioid receptors are key targets for pain management.
- Current opioid therapies cause adverse effects like tolerance, dependence, and respiratory depression.
- Indole alkaloids offer a potential novel mechanism for analgesia.
Purpose of the Study:
- To investigate the mechanism of action of indole alkaloids on opioid receptors.
- To explore the potential of indole alkaloids in developing safer analgesics.
Main Methods:
- Investigated the interaction of indole alkaloids (ibogaine, mitragynine) with μ-opioid receptors.
- Assessed the recruitment of β-arrestin and G-protein signaling pathways.
- Proposed a molecular mechanism for biased agonism based on structural interactions.
Main Results:
- Indole alkaloids act as biased agonists at μ-opioid receptors.
- They exhibit reduced β-arrestin recruitment compared to non-biased agonists.
- This biased activation is linked to a distinct spatial orientation of receptor residues.
Conclusions:
- Naturally occurring indole alkaloids mediate biased G-protein-coupled activation of opioid receptors.
- Limited β-arrestin recruitment by indole alkaloids may reduce common opioid adverse effects.
- Indole alkaloids represent a viable structural basis for developing novel biased opioid modulators with improved safety profiles.
More Related Videos
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioid Analgesics: Morphine and Other Natural Cogeners